Establishment of a new cell line of endometrioid carcinoma of the ovary and its chemosensitivity

Human Cell

Volumn 20, Issue 3, 2007, Pages 71-76

  Umezu, Tomokazu ^a   Kajiyama, Hiroaki ^a   Terauchi, Mikio ^a   Shibata, Kiyosumi ^a   Ino, Kazuhiko ^a   Nawa, Akihiro ^a   Kikkawa, Fumitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemosensitivity; Endometrioid carcinoma; Establishment; Nude mouse; Ovarian carcinoma

Indexed keywords

CARBOPLATIN; CISPLATIN; ESTROGEN RECEPTOR ALPHA; PACLITAXEL;

ADJUVANT THERAPY; ADULT; ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL LINE; CELL STRUCTURE; CHEMOSENSITIVITY; CHROMOSOME NUMBER; CONTACT INHIBITION; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; HUMAN CELL; IC 50; NONHUMAN; NUDE MOUSE; OVARY CARCINOMA; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CA-125 ANTIGEN; CARBOPLATIN; CARCINOMA, ENDOMETRIOID; CELL DIVISION; CELL LINE, TUMOR; CHROMOSOMES, HUMAN; CISPLATIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MIDDLE AGED; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; PACLITAXEL;

MUS MUSCULUS;

EID: 34447544668     PISSN: 09147470     EISSN: 17490774     Source Type: Journal    
DOI: 10.1111/j.1749-0774.2007.00030.x     Document Type: Article

References (16)

1. Kurman RJ, eds. Blaustein's Pathology of the Female Genital Tract, 4th edn. New York: Springer-Verlag, 1994 705 82.
2. Zwart J, Geisler JP, Geisler HE. Five-year survival in patients with endometrioid carcinoma of the ovary versus those with serous carcinoma. Eur J Gynaecol Oncol 1998 19: 225 8.
3. Kobayashi Y, Mizuhara H, Ohara T et al. Establishment and characterization of a cell line derived from a human serous surface papillary carcinoma of the ovary. Hum Cell 2006 19: 133 7.
4. Aoki D, Suzuki N, Susumu N et al. Establishment and characterization of the RMG-V cell line from human ovarian clear cell adenocarcinoma. Hum Cell 2005 18: 143 6.
5. Sato S, Kobayashi Y, Okuma Y et al. Establishment and characterization of a cell-line originated from human mucinous cystadenocarcinoma of the ovary. Hum Cell 2002 15: 171 7.
6. Saga Y, Suzuki M, Machida S, Ohwada M, Sato I. Establishment of a new cell line (TAYA) of clear cell adenocarcinoma of the ovary and its radiosensitivity. Oncology 2002 62: 180 84.
7. Emoto M, Oshima K, Ishiguro M, Iwasaki H, Kawarabayashi T, Kikuchi M. Establishment and characterization of a serous papillary adenocarcinoma cell line of the human ovary in a serum-free culture. Pathol Res Pract 1999 195: 237 42.
8. Yamada T, Ueda M, Otsuki Y, Ueki M, Sugimoto O. Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary. Gynecol Oncol 1991 40: 118 28.
9. Wong WS, Wong YF, Ng YT et al. Establishment and characterization of a new human cell line derived from ovarian clear cell carcinoma. Gynecol Oncol 1990 38: 37 45.
10. Briers TW, Stroobants P, Vandeputte TM et al. Establishment and characterization of a human ovarian neoplastic cell line, DO-s. Cancer Res 1989 49: 5153 61.
11. Terauchi M, Kajiyama H, Shibata K, Ino K, Mizutani S, Kikkawa F. Anti-progressive effect of neutral endopeptidase 2411 (NEP/CD10) on cervical carcinoma in vitro and in vivo. Oncology 2005 69: 52 62. [Epub 12 August 2005].
12. Glavind K, Grove A. Estrogen and progesterone receptors in epithelial ovarian tumors. APMIS 1990 98: 916 20.
13. Grosso G, Raspagliesi F, Baiocchi G, Di Re E, Colavita M, Cobellis L. Endometrioid carcinoma of the ovary: a retrospective analysis of 106 cases. Tumori 1998 84: 552 7.
14. Zhang Y, Liao Q, Chen C, Yu L, Zhao J. Function of estrogen receptor isoforms alpha and beta in endometrial carcinoma cells. Int J Gynecol Cancer 2006 16: 1656 60.
15. Mizumoto H, Saito T, Ashihara K, Nishimura M, Tanaka R, Kudo R. Acceleration of invasive activity via matrix metalloproteinases by transfection of the estrogen receptor-alpha gene in endometrial carcinoma cells. Int J Cancer 2002 100: 401 6.
16. Taylor AH, al-Azzawi F, Pringle JH, Bell SC. Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotides. Anticancer Res 2002 22: 3993 4003.